Companies / Brazil
Boehringer Eyes Brazilian OTC Market
August 2006 | Company Finance AlertGerman drugmaker Boehringer Ingelheim (BI) is set to expand its presence in the Brazilian OTC market, as it looks to bolster its portfolio. The company markets several market-leading brands including the anti-spasmodic Buscopan and Mucusolvan, and has already boosted its marketing budget 17% to US$75mn in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
